Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Muath Alobaida, Abdullah Alrumayh, Ayodipupo S Oguntade, Faez Al-Amodi & Mwango Bwalya. (2021) Cardiovascular Safety and Superiority of Anti-Obesity Medications. Diabetes, Metabolic Syndrome and Obesity 14, pages 3199-3208.
Read now
Read now
Dhiren K Patel & Fatima Cody Stanford. (2018) Safety and tolerability of new-generation anti-obesity medications: a narrative review. Postgraduate Medicine 130:2, pages 173-182.
Read now
Read now
Articles from other publishers (26)
Alyse S. Goldberg, Samin Dolatabadi, Heidi Dutton & Jamie L. Benham. (2023) Navigating the Role of Anti-Obesity Agents Prior to Pregnancy: A Narrative Review. Seminars in Reproductive Medicine.
Crossref
Crossref
Jacob Levi, Junzheng Wang, Francois Venter & Andrew Hill. (2023) Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment. Obesity 31:5, pages 1270-1279.
Crossref
Crossref
Xue Wen, Bohan Zhang, Beiyi Wu, Haitao Xiao, Zehua Li, Ruoyu Li, Xuewen Xu & Tao Li. (2022) Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Monica Alhadas Scudeler, Stephania Morreale, Lorena Doretto-Silva, Giuliana Petri, José Francisco Ramos dos Santos, Cristina Nassis, Olga Maria de Toledo Correa & Juliana Mora Veridiano. (2022) Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats. einstein (São Paulo) 20.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
199
229
.
Terrance A. Maguire. 2022. Bariatric Surgery in Clinical Practice. Bariatric Surgery in Clinical Practice
59
64
.
Mona Gossmann, W. Scott Butsch & Ania M. Jastreboff. (2021) Treating the Chronic Disease of Obesity. Medical Clinics of North America 105:6, pages 983-1016.
Crossref
Crossref
Agni Kakouri, Georgia Kanti, Efthymios Kapantais, Alexandros Kokkinos, Leonidas Lanaras, Paul Farajian, Christos Galanakis, Georgios Georgantopoulos, Nikos F. Vlahos, George Mastorakos, Alexandra Bargiota & Georgios Valsamakis. (2021) New Incretin Combination Treatments under Investigation in Obesity and Metabolism: A Systematic Review. Pharmaceuticals 14:9, pages 869.
Crossref
Crossref
Lisa GillSuzanne Mackey. (2021) Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists. Journal of Women's Health 30:7, pages 1016-1027.
Crossref
Crossref
Xiang‐Guo Lei, Jia‐Qi Ruan, Chen Lai, Ziyi Sun & Xi Yang. (2021) Efficacy and Safety of Phentermine/Topiramate in Adults with Overweight or Obesity: A Systematic Review and Meta‐Analysis. Obesity 29:6, pages 985-994.
Crossref
Crossref
Carlos M. Jimenez-Munoz, Marta López, Fernando Albericio & Kamil Makowski. (2021) Targeting Energy Expenditure—Drugs for Obesity Treatment. Pharmaceuticals 14:5, pages 435.
Crossref
Crossref
Elvira Anna Carbone, Mariarita Caroleo, Marianna Rania, Giuseppina Calabrò, Filippo Antonio Staltari, Renato de Filippis, Matteo Aloi, Francesca Condoleo, Franco Arturi & Cristina Segura-Garcia. (2020) An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 26:3, pages 779-788.
Crossref
Crossref
Xuelian Zhang, Bin Zhang, Chenyang Zhang, Guibo Sun & Xiaobo Sun. (2021) Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss. Frontiers in Pharmacology 11.
Crossref
Crossref
Bapi Gorain, Hira Choudhury, Pallav Sengupta, Rohit Kumar Verma & Manisha Pandey. 2021. Obesity and its Impact on Health. Obesity and its Impact on Health
125
148
.
Gayane Sargis Vardanyan, Hasmik Samvel Harutyunyan, Michail Iosif Aghajanov & Ruben Sargis Vardanyan. (2020) Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects. Future Medicinal Chemistry 12:20, pages 1865-1884.
Crossref
Crossref
Luigi Barrea, Gabriella Pugliese, Giovanna Muscogiuri, Daniela Laudisio, Annamaria Colao & Silvia Savastano. (2020) New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists. Minerva Endocrinologica 45:2.
Crossref
Crossref
Michail Natsis, Christina Antza, Ioannis Doundoulakis, Stella Stabouli & Vasilios Kotsis. (2020) Hypertension in Obesity: Novel Insights. Current Hypertension Reviews 16:1, pages 30-36.
Crossref
Crossref
Akiko Tanaka, Kentaro Takayama, Tomoyuki Furubayashi, Kenji Mori, Yuki Takemura, Mayumi Amano, Chiaki Maeda, Daisuke Inoue, Shunsuke Kimura, Akiko Kiriyama, Hidemasa Katsumi, Mikiya Miyazato, Kenji Kangawa, Toshiyasu Sakane, Yoshio Hayashi & Akira Yamamoto. (2019) Transnasal Delivery of the Peptide Agonist Specific to Neuromedin-U Receptor 2 to the Brain for the Treatment of Obesity. Molecular Pharmaceutics 17:1, pages 32-39.
Crossref
Crossref
Genovefa D. Kolovou, Gerald F. Watts, Dimitri P. Mikhailidis, Pablo Pérez-Martínez, Samia Mora, Helen Bilianou, George Panotopoulos, Niki Katsiki, Teik C. Ooi, José Lopez-Miranda, Anne Tybjærg-Hansen, Nicholas Tentolouris & Børge G. Nordestgaard. (2019) Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. Current Vascular Pharmacology 17:5, pages 515-537.
Crossref
Crossref
Pamela Rosa-Gonçalves & David Majerowicz. (2019) Pharmacotherapy of Obesity: Limits and Perspectives. American Journal of Cardiovascular Drugs 19:4, pages 349-364.
Crossref
Crossref
Pei-Chi Chan, Min-Tser Liao & Po-Shiuan Hsieh. (2019) The Dualistic Effect of COX-2-Mediated Signaling in Obesity and Insulin Resistance. International Journal of Molecular Sciences 20:13, pages 3115.
Crossref
Crossref
Beatriz T. Meneguetti, Marlon H. Cardoso, Camila F.A. Ribeiro, Mário R. Felício, Ingrid B. Pinto, Nuno C. Santos, Cristiano M.E. Carvalho & Octávio L. Franco. (2019) Neuropeptide receptors as potential pharmacological targets for obesity. Pharmacology & Therapeutics 196, pages 59-78.
Crossref
Crossref
Gabriela Y. Cortés-Moreno, José E. Roa-Coria, Ángel Zúñiga-Romero, Juan C. Huerta-Cruz, Eleazar Lara-Padilla, Cecilia F. del Valle-Laisequilla, Héctor I. Rocha-González & Juan G. Reyes-García. (2018) Anorectic efficacy and safety of the diethylpropion-topiramate combination in rats. Drug Development Research 79:5, pages 225-233.
Crossref
Crossref
Donald E. Greydanus, Marisha Agana, Manmohan K. Kamboj, Saad Shebrain, Neelkamal Soares, Ransome Eke & Dilip R. Patel. (2018) Pediatric obesity: Current concepts. Disease-a-Month 64:4, pages 98-156.
Crossref
Crossref
Weijing Wang, Wenjie Jiang, Lin Hou, Haiping Duan, Yili Wu, Chunsheng Xu, Qihua Tan, Shuxia Li & Dongfeng Zhang. (2017) Weighted gene co-expression network analysis of expression data of monozygotic twins identifies specific modules and hub genes related to BMI. BMC Genomics 18:1.
Crossref
Crossref
John PH Wilding. (2017) Combination therapy for obesity. Journal of Psychopharmacology 31:11, pages 1503-1508.
Crossref
Crossref